Creative Medical Technology Holdings (CELZ) Inventory (2020 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Inventory of $125000.0 for Q1 2026, up 12475.45% year-over-year from N/an in Q1 2025, and up 12475.45% quarter-over-quarter from $994.0 in Q3 2025.
Creative Medical Technology Holdings (CELZ) Inventory (2020 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Inventory for 7 consecutive years, with $125000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 12475.45% year-over-year to $125000.0; the TTM figure through Mar 2026 stood at $125000.0 (up 12475.45% YoY), while the FY2024 annual figure was $2194.0, down 66.73% from the prior year.
- Inventory advanced to $125000.0 in Q1 2026 per CELZ's latest filing, from $994.0 in the prior quarter.
- Across five years, Inventory topped out at $125000.0 in Q1 2026 and bottomed at $994.0 in Q1 2025.
- Historically, Inventory has averaged $14949.8 across 5 years, with a median of $7194.0 in 2023.
- Annual changes were most pronounced in 2025 — Inventory slumped 84.93% — and 2026, when it jumped 12475.45%.
- Creative Medical Technology Holdings' Inventory stood at $10194.0 in 2022, then tumbled by 35.31% to $6594.0 in 2023, then slumped by 66.73% to $2194.0 in 2024, then slumped by 54.69% to $994.0 in 2025, then surged by 12475.45% to $125000.0 in 2026.
- Business Quant data shows CELZ's Inventory at $125000.0 in Q1 2026, $994.0 in Q3 2025, and $994.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Sep 30, 2025 | 994.00 |
| Jun 30, 2025 | 994.00 |
| Mar 31, 2025 | 994.00 |
| Dec 31, 2024 | 2,194.00 |
| Sep 30, 2024 | 3,394.00 |
| Jun 30, 2024 | 3,394.00 |
| Mar 31, 2024 | 6,594.00 |
| Dec 31, 2023 | 6,594.00 |
| Sep 30, 2023 | 7,794.00 |
| Jun 30, 2023 | 10,194.00 |
| Mar 31, 2023 | 10,194.00 |
| Dec 31, 2022 | 10,194.00 |
| Sep 30, 2022 | 15,894.00 |
| Jun 30, 2022 | 20,625.00 |
| Mar 31, 2022 | 14,150.00 |
| Dec 31, 2021 | 10,866.00 |
| Jun 30, 2020 | 1,200.00 |
| Mar 31, 2020 | 2,800.00 |